|Conjoint analysis applications in health—a checklist: a report of the ISPOR Good Research Practices for Conjoint Analysis Task Force|
JFP Bridges, AB Hauber, D Marshall, A Lloyd, LA Prosser, DA Regier, ...
Value in health 14 (4), 403-413, 2011
|Constructing experimental designs for discrete-choice experiments: report of the ISPOR conjoint analysis experimental design good research practices task force|
FR Johnson, E Lancsar, D Marshall, V Kilambi, A Mühlbacher, DA Regier, ...
Value in health 16 (1), 3-13, 2013
|Evaluating health-related quality-of-life studies in paediatric populations|
M De Civita, D Regier, AH Alamgir, AH Anis, MJ FitzGerald, CA Marra
Pharmacoeconomics 23 (7), 659-685, 2005
|Handbook of statistics in clinical oncology|
J Crowley, A Hoering
CRC Press, 2012
|Cost-effectiveness of self-managed versus physician-managed oral anticoagulation therapy|
DA Regier, R Sunderji, LD Lynd, K Gin, CA Marra
CMAJ 174 (13), 1847-1852, 2006
|An overview of economic evaluations for drugs used in rheumatoid arthritis|
NJ Bansback, DA Regier, R Ara, A Brennan, K Shojania, JM Esdaile, ...
Drugs 65 (4), 473-496, 2005
|Chemotherapy versus supportive care alone in pediatric palliative care for cancer: comparing the preferences of parents and health care professionals|
D Tomlinson, U Bartels, J Gammon, PS Hinds, J Volpe, E Bouffet, ...
Cmaj 183 (17), E1252-E1258, 2011
|Societal preferences for the return of incidental findings from clinical genomic sequencing: a discrete-choice experiment|
DA Regier, SJ Peacock, R Pataky, K Van Der Hoek, GP Jarvik, J Hoch, ...
Cmaj 187 (6), E190-E197, 2015
|Bayesian and classical estimation of mixed logit: an application to genetic testing|
DA Regier, M Ryan, E Phimister, CA Marra
Journal of health economics 28 (3), 598-610, 2009
|Return of incidental findings in genomic medicine: measuring what patients value—development of an instrument to measure preferences for information from next-generation …|
CS Bennette, SB Trinidad, SM Fullerton, D Patrick, L Amendola, W Burke, ...
Genetics in Medicine 15 (11), 873-881, 2013
|Multi-criteria decision analysis to support healthcare decisions|
K Marsh, M Goetghebeur, P Thokala, R Baltussen
Springer International Publishing 10, 978-3, 2017
|Value for money? Array genomic hybridization for diagnostic testing for genetic causes of intellectual disability|
DA Regier, JM Friedman, CA Marra
The American Journal of Human Genetics 86 (5), 765-772, 2010
|Pan-cancer analysis of advanced patient tumors reveals interactions between therapy and genomic landscapes|
E Pleasance, E Titmuss, L Williamson, H Kwan, L Culibrk, EY Zhao, ...
Nature Cancer 1 (4), 452-468, 2020
|Valuing the benefit of diagnostic testing for genetic causes of idiopathic developmental disability: willingness to pay from families of affected children|
DA Regier, JM Friedman, N Makela, M Ryan, CA Marra
Clinical genetics 75 (6), 514-521, 2009
|Methodological issues in assessing the economic value of next-generation sequencing tests: many challenges and not enough solutions|
KA Phillips, PA Deverka, DA Marshall, S Wordsworth, DA Regier, ...
Value in Health 21 (9), 1033-1042, 2018
|The cost and cost trajectory of whole‐genome analysis guiding treatment of patients with advanced cancers|
D Weymann, J Laskin, R Roscoe, KA Schrader, S Chia, S Yip, ...
Molecular genetics & genomic medicine 5 (3), 251-260, 2017
|Valuation of health and nonhealth outcomes from next-generation sequencing: approaches, challenges, and solutions|
DA Regier, D Weymann, J Buchanan, DA Marshall, S Wordsworth
Value in Health 21 (9), 1043-1047, 2018
|Health-related quality of life anticipated with different management strategies for paediatric febrile neutropaenia|
S Cheng, O Teuffel, MC Ethier, C Diorio, J Martino, C Mayo, D Regier, ...
British journal of cancer 105 (5), 606-611, 2011
|Resource utilization and costs during the initial years of lung cancer screening with computed tomography in Canada|
S Cressman, S Lam, MC Tammemagi, WK Evans, NB Leighl, DA Regier, ...
Journal of thoracic oncology 9 (10), 1449-1458, 2014
|Cost-effectiveness of therapeutic hypothermia to treat neonatal encephalopathy|
DA Regier, S Petrou, J Henderson, O Eddama, N Patel, B Strohm, ...
Value in Health 13 (6), 695-702, 2010